NCT07588646 Study To Investigate The Potential DDI Between HEC585 And Pirfenidone/Nintedanib In Healthy Subjects Status COMPLETED Phase PHASE1
NCT07454291 A Study to Evaluate Pharmacokinetics and Drug-drug Interactions of ENV-101 (Taladegib) in Healthy Participants Status RECRUITING Phase PHASE1
NCT07335562 A Study to Compare the Efficacy and Safety of BMS-986353 (Zolacabtagene- Autoleucel / Zola-cel), CD19-CAR T Cells, Versus Standard of Care in Participants With Active Systemic Sclerosis Status RECRUITING Phase PHASE3
NCT07162961 Nintedanib for Improving Reproductive Outcomes in Adenomyosis Status NOT_YET_RECRUITING Phase PHASE3
NCT07015398 A Study of the Pharmacokinetic Interaction Between Pirfenidone, Nintedanib, and Nalbuphine Extended Release (NAL ER) in Healthy Participants Status COMPLETED Phase PHASE1
NCT06643091 Nintedanib Treatment in Unicentric Castleman Disease Status NOT_YET_RECRUITING Phase PHASE2
NCT06625489 A Study to Evaluate the Safety, Tolerability and Blood Levels of GSK3915393 Administered to Healthy Participants of Chinese, Japanese and European Ancestry and to Assess Effects of GSK3915393 on Nintedanib Status COMPLETED Phase PHASE1
NCT06570317 Nintedanib for the Prevention of Radiation Pneumonia in Unresectable NSCLC Status RECRUITING Phase N/A
NCT06568458 A Study to Assess the Extent of Drug Interaction Between BMS-986278 and Nintedanib, the Relative Bioavailability of BMS-986278 in Tablet and the Effect That Food Has on BMS-986278 in Tablet Formulations in Healthy Participants Status COMPLETED Phase PHASE1
NCT06297096 Study of the Efficacy of Nintedanib+Tocilizumab in Patients With Systemic Sclerosis and Interstitial Lung Disease Status RECRUITING Phase PHASE3
NCT06200714 A Study Based on Medical Records in Spain That Looks at Diarrhoea Control in People With Pulmonary Fibrosis Who Are Taking Nintedanib Status COMPLETED Phase N/A
NCT06070610 A Study in Healthy Men to Test Whether BI 1015550 Influences the Amount of Nintedanib and Pirfenidone in the Blood Status COMPLETED Phase PHASE1
NCT05870956 Burden of Nintedanib Non-adherence Among Idiopathic Pulmonary Fibrosis (IPF) Patients Status COMPLETED Phase N/A
NCT05817240 A Drug-Drug Interaction Study of ENV-101 (Taladegib) on Nintedanib Pharmacokinetics in Healthy Subjects Status COMPLETED Phase PHASE1
NCT05779007 Dose Reduction and Discontinuation With Anti-Fibrotic Medications Status COMPLETED Phase N/A
NCT05644600 A Study to Assess the Effect of AZD5055 on the Pharmacokinetics (PK) of Nintedanib in Healthy Participants. Status TERMINATED Phase PHASE1